How to determine if you’re at risk for adult ADHD
UC expert featured in National Geographic article
The University of Cincinnati's Stephen Rush was featured in a National Geographic article discussing current research into the causes and characteristics of ADHD, particularly when it is diagnosed in adults.
"The predominant theory is primarily genetics and the biology of what’s going on in the brain that seems to be associated with it," said Rush, MD, associate professor of clinical psychiatry in UC's College of Medicine, medical director of ambulatory services and a UC Health physician. Studies show that about 80 percent of the time there is a similar genetic component found among people who have ADHD compared to people who do not have it.
Our brains have “a polygenic architecture,” Rush continued. “And what that means is that there are hundreds of potential genes contributing to small effects. Their interaction, and the interaction that those genes have, even with the environment, shapes the risk for a diagnosis of ADHD.”
Read the National Geographic article.
Featured photo at top of wooden blocks spelling ADHD. Photo/anilakkus/iStock Photo.
Related Stories
UC launches Bearcats Affordability Grant
January 7, 2026
The University of Cincinnati is making college more attainable for students across Ohio with the creation of the Bearcats Affordability Grant. The new grant will provide a pathway to tuition-free college for students of families who make less than $75,000 per year. Beginning in fall 2026, the Bearcats Affordability Grant will cover the remaining cost of tuition for Ohio residents who are Pell eligible.
BearcatGPT AI platform now available to all UC faculty and staff
December 9, 2025
University of Cincinnati Digital Technology Solutions is excited to announce that BearcatGPT, the university’s private, secure AI platform, is now available to all UC faculty and staff.
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.